UNC Lineberger
UNC Lineberger Comprehensive Cancer Center is North Carolina's only public NCI-designated comprehensive cancer center, conducting translational genomics, clinical trials, population science, and community outreach research while delivering cancer care through UNC Health and serving patients, researchers, and communities statewide.
- Company typePrivate
- Founded1972
- HeadquartersChapel Hill, United States
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingServices
What UNC Lineberger does
UNC Lineberger Comprehensive Cancer Center, founded in 1972, is North Carolina's only public NCI-designated comprehensive cancer center, operating as an integral component of the University of North Carolina at Chapel Hill School of Medicine and affiliated with UNC Health. It functions as a research, clinical care, and training institution serving cancer patients, researchers, and communities across North Carolina. Its service portfolio spans eight research programs, three Centers of Excellence (bladder, endometrial, pancreatic cancer), and more than 20 center initiatives. Funding flows predominantly from the NCI Cancer Center Support Grant (P30 CA016086), the state-funded University Cancer Research Fund, NIH training grants, and sponsored research agreements; revenue from clinical trial management and core facility fee-for-service represents a secondary stream.
Its core technology and service infrastructure comprises shared resources organized into Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores. Key facilities include the Translational Genomics Lab (high-throughput nucleic acid extraction, NGS library preparation, and sequencing at 20,000+ sample scale), the Tissue Culture Facility (400+ cell line repository), Rapid Case Ascertainment (statewide NC Cancer Registry interface supporting 900+ publications), and the MaTRIC project management platform launched in 2022 for population science research. Proprietary assets include the UNCseq targeted DNA sequencing panel and electronic patient-reported outcomes tools integrated into Epic EHR systems and used in global clinical trials. The center's clinical research infrastructure is operationalized through the Clinical Trials Office supporting investigator-initiated and industry-sponsored trials across breast, lung, prostate, sarcoma, and other oncology indications.
Its go-to-market model is sales-led via clinical referrals and community outreach, complemented by academic convening functions. Patient care is delivered through UNC Health facilities across North Carolina, extended statewide through the UNC Lineberger Cancer Network (telemedicine and community physician partnerships). Research services are sold fee-for-service to UNC investigators (subsidized) and external clients, while genomic and bioinformatic tools scale nationally via Epic integration and the OncoPRO initiative (with ASCO and the American Cancer Society) across 20+ health systems. Customer segments are hybrid: cancer patients (clinical care), academic and clinician-scientists (shared resources, training), referring physicians and health systems (specialty referrals and tool adoption), and rural/underserved NC communities (screening and outreach partnerships with organizations such as Kintegra Health and Raleigh Housing Authority).
UNC Lineberger firmographics
Firmographics- Name
- UNC Lineberger
- Legal name
- UNC Lineberger Comprehensive Cancer Center
- Website
- https://unclineberger.org
- Company type
- Private
- Founded year
- 1972
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- UNC Lineberger Comprehensive Cancer Center is North Carolina's only public NCI-designated comprehensive cancer center, conducting translational genomics, clinical trials, population science, and community outreach research while delivering cancer care through UNC Health and serving patients, researchers, and communities statewide.
- Ownership category
- akta.pro rank
UNC Lineberger industry classification
Industry- Product category
- Cancer Research and Treatment
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Colleges, Universities, and Professional Schools (611310)
- SIC
- Services-Medical Laboratories (8071), Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Surgical Oncology (HLAKAFAG)
Keywords
Where UNC Lineberger is headquartered
LocationHeadquarters
- HQ city
- Chapel Hill
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
UNC Lineberger business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Government Research Grants and NCI Funding: UNC Lineberger is an NCI-designated comprehensive cancer center supported by NCI Cancer Center Support Grant P30 CA016086, NIH-funded training grants (T32), and other peer-reviewed cancer-focused research grants. Membership is subject to NCI review and is largely provided to investigators holding NCI or other NIH funding.
- University Cancer Research Fund (UCRF): State-funded cancer research investment created by the N.C. General Assembly in 2007. Began with $25 million in 2007 and grew to $59.5 million by 2022. Funds discovery, innovation, and delivery of improved cancer care across North Carolina.
- Clinical Trial Revenue: UNC Lineberger's Clinical Trials Office turns research concepts into operational clinical trials, supporting investigator-initiated and industry-sponsored trials. Revenue is generated through clinical research management services, per-trial accruals, and industry sponsorship agreements.
- Shared Resource Service Fees: Core facilities (Tissue Culture, Translational Genomics Lab, Bioinformatics, etc.) provide services to UNC researchers and external clients on a fee-for-service basis, subsidized for UNC Lineberger members. Services include genomic sequencing, cell line repositories, imaging, and analytical support.
- Rapid Case Ascertainment Fees: RCA charges fees on a fee-for-service basis for facilitating cancer prevention and control research requiring early patient contact through the North Carolina Central Cancer Registry.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Translational Genomics Lab service rates for UNC investigators |
| Other | Pay-as-you-go | Patient care and clinical trial services |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
UNC Lineberger product offering
Product offeringCore offering
UNC Lineberger is an NCI-designated Comprehensive Cancer Center that conducts basic, translational, and clinical cancer research, delivers multidisciplinary cancer patient care through affiliated clinical facilities, trains the next generation of cancer researchers and clinicians, and operates shared research resources and population health tools. [Inferred from entity name and standard NCI cancer center mission]
Product overview
UNC Lineberger Comprehensive Cancer Center is North Carolina's only public, NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer research, clinical care, and educational services. The center operates multiple interconnected core facilities and programs including the Translational Genomics Lab (providing genomic sequencing and profiling), Tissue Culture Facility (providing cell lines and reagents), and Rapid Case Ascertainment (enabling early patient recruitment for cancer research). Additional key services include the Clinical Trials Office for operationalizing clinical trials, MaTRIC for population science research project management, Cancer Registry for cancer surveillance data, and the CRTEC training program. The center has developed Patient-Reported Outcomes electronic tools now integrated into Epic EHR systems. Shared Resources span Animal Models, Basic Sciences, Clinical/Translational, Genomics/Proteomics, Population Sciences, and Research Support cores serving the research community.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Clinical Trials Program Conducts investigator-initiated and cooperative-group oncology clinical trials for cancer patients across multiple disease sites.
- Translational Genomics Lab Shared resource providing next-generation sequencing and molecular profiling services for cancer researchers.
- Tissue Culture Facility Shared resource providing cell culture, hybridoma, and monoclonal antibody production services for cancer investigators.
- Rapid Case Ascertainment (RCA) Service that rapidly identifies and recruits eligible cancer patients into research studies using the UNC Cancer Registry.
- Cancer Information & Population Health Resource (CIPHR) Resource linking cancer registry data with administrative, claims, and clinical data for population-based cancer outcomes research.
- UNC Cancer Registry Central cancer registry covering North Carolina that collects and manages cancer incidence data for surveillance and research.
- Cancer Research Training & Education Coordination (CRTEC) Coordinates cancer-relevant training programs for students, postdoctoral fellows, and early-career investigators.
Quantifiable outcome
- Patient-reported outcome tools improved clinicians' awareness of patient symptoms and accelerated care, leading to better symptom control, improved quality of life, fewer hospitalizations, and longer survival for cancer patients
- +4 more outcomes
Companies that use UNC Lineberger
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles2 records
UNC Lineberger technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature6 records
UNC Lineberger partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- ZERO Prostate CancercoreUNC Lineberger received a 2026 Bayer Community Innovation Grant from ZERO Prostate Cancer to expand prostate cancer screening in rural North Carolina through the Check & Protect: UNC Prostate Cancer Awareness and Screening Initiative. This community-based pilot program aims to expand education, screening, and early detection among men at increased risk. UNC Lineberger was one of only five organizations nationwide selected.
- Strides for Sarcoma FoundationcoreAwarded $40,000 Maia James Sarcoma Innovation Grant to Pengda Liu for developing novel antibody-drug conjugates to facilitate clinical translation of new targeted therapies for sarcoma.
- Prostate Health Education Network (PHEN)coreUNC Department of Urology and UNC Lineberger provided clinical leadership for statewide prostate cancer awareness initiatives, supporting PHEN-organized rallies and community health events focused on education, awareness, and early detection across North Carolina.
- Kintegra HealthcoreCommunity health center partner that launched 'Mega Day' events bringing cancer screening services together in family-friendly, convenient locations close to where patients live, improving access to preventive health services.
- Raleigh Housing AuthorityminorPartnered with UNC Lineberger Community Outreach and Engagement office to host Health and Wellness Fairs offering cancer education, prostate cancer screenings, and preventive health resources to nearly 50 community members.
- North Carolina Central Cancer Registry (CCR)coreRCA is a collaboration between UNC Lineberger, the North Carolina Central Cancer Registry, and participating hospitals. CCR accelerates reporting for quick identification of cancer patients throughout the state, enabling early patient contact for prevention and control research.
- American Society of Clinical Oncology (ASCO)coreUNC Lineberger partners with ASCO as part of the OncoPRO national initiative to provide health systems with training, patient education materials, and technical support for implementing PRO tools in cancer care.
- American Cancer SocietycorePartner in OncoPRO initiative alongside ASCO to implement patient-reported outcome tools across US health systems, improving symptom tracking and cancer care outcomes.
- OncoPRO Participating Health SystemscoreMore than 20 health systems across the US, including UNC Health, East Carolina University, Wake Forest University, and Duke University, are implementing PRO tools through the OncoPRO initiative led by UNC Lineberger.
- UNC HealthcoreUNC Health is the affiliated health system providing inpatient and outpatient cancer treatment services. UNC Lineberger is the cancer center embedded within UNC School of Medicine, with patient care delivered through UNC Health facilities.
- Epic SystemscorePatient-reported outcome tools developed by UNC Lineberger are now integrated into Epic electronic health record systems and available for use by health systems across the United States and Europe.
Scale indicators14 records
Recent moves6 records
Expansion highlights6 records
UNC Lineberger competitors and assessment
Company assessmentDirect peers
- Duke Cancer Institute: NCI-designated Comprehensive Cancer Center at Duke University, also located in North Carolina's Research Triangle. Directly comparable as an academic comprehensive cancer center delivering oncology research, clinical trials, and patient care in the same geographic market.
- Wake Forest Baptist Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at Atrium Health Wake Forest Baptist. Peer academic cancer center competing for the same North Carolina patient population, faculty, and pharma-sponsored trials.
- Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center in the Southeast US. Comparable as an academic cancer center with research programs, shared resources, clinical trials, and community outreach in a similar regional academic setting.
- Vanderbilt-Ingram Cancer Center: NCI-designated Comprehensive Cancer Center at Vanderbilt University Medical Center. Compares closely in research program structure, translational genomics, clinical trial infrastructure, and academic medical center affiliation.
Regional players
- UNC Lineberger Cancer Network affiliate cancer centers (e.g., East Carolina University, Coastal Carolina): Regional oncology partners across North Carolina that coordinate cancer care and clinical trial access through the UNC Lineberger Cancer Network, extending the center's reach to underserved communities.
Broad incumbents
- MD Anderson Cancer Center: The largest NCI-designated Comprehensive Cancer Center in the US, operating at a much larger scale. Comparable in NCI designation, research breadth, and clinical-trial volume, but far larger and more national in reach.
- Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center with deep translational research, genomic profiling, and clinical trial capabilities. Comparable scope of basic, translational, and clinical oncology research, though at substantially larger scale.
- Sidney Kimmel Cancer Center (Johns Hopkins): NCI-designated Comprehensive Cancer Center with extensive translational genomics, clinical trials, and research programs. Comparable research breadth but operates at a substantially larger national scale.
- Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center with strong translational science, clinical trial infrastructure, and population-based research. Comparable research scope and NCI designation, though with a different structural affiliation (independent research center).
- UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center combining translational research, precision oncology, and clinical trials within a major academic medical center. Comparable in NCI designation and research breadth, but anchored in a different regional market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
UNC Lineberger social profiles
Digital presenceUNC Lineberger compliance and trust
Trust signalCompliance1 record
UNC Lineberger financial estimates
Financial estimateRevenue estimate
Valuation estimate
UNC Lineberger leadership team
Management profileNumber of profiles
Profiles1 record
UNC Lineberger funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UNC Lineberger M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UNC Lineberger
What does UNC Lineberger do?
UNC Lineberger is an NCI-designated Comprehensive Cancer Center that conducts basic, translational, and clinical cancer research, delivers multidisciplinary cancer patient care through affiliated clinical facilities, trains the next generation of cancer researchers and clinicians, and operates shared research resources and population health tools. [Inferred from entity name and standard NCI cancer center mission]
Is UNC Lineberger a public or private company?
UNC Lineberger is a private company. It is classified as state government owned and is currently operating.
When was UNC Lineberger founded?
UNC Lineberger was founded in 1972. It employs 1,001 to 5,000 people.
Where is UNC Lineberger based?
UNC Lineberger is headquartered in Chapel Hill, United States, in the North America region.
How does UNC Lineberger make money?
Five revenue lines are on record. Government Research Grants and NCI Funding is the primary driver. The others are university Cancer Research Fund (UCRF), clinical Trial Revenue, shared Resource Service Fees and rapid Case Ascertainment Fees.
Who are UNC Lineberger's main competitors?
Direct peers on record are Duke Cancer Institute, Wake Forest Baptist Comprehensive Cancer Center, Winship Cancer Institute of Emory University and Vanderbilt-Ingram Cancer Center. UNC Lineberger Cancer Network affiliate cancer centers (e.g., East Carolina University, Coastal Carolina) is listed as a regional player. Broad incumbents are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Cancer Center (Johns Hopkins), Fred Hutchinson Cancer Center and UCSF Helen Diller Family Comprehensive Cancer Center.
Does UNC Lineberger have an API?
No public API is recorded for UNC Lineberger.
What industry is UNC Lineberger in?
UNC Lineberger's product category is Cancer Research and Treatment. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8071.